Bio-Techne
TECH
#1834
Rank
NZ$20.24 B
Marketcap
NZ$129.12
Share price
0.01%
Change (1 day)
23.36%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): NZ$2.04

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$2.08. In 2025 the company made an earnings per share (EPS) of NZ$0.93 a decrease over its 2024 EPS that were of NZ$1.78.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.04119.7%
2025NZ$0.93-48%
2024NZ$1.78-29.58%
2023NZ$2.53-14.97%
2022NZ$2.9824.16%
2021NZ$2.4017.98%
2020NZ$2.03-10.94%
2019NZ$2.28101.57%
2018NZ$1.13-16.99%
2017NZ$1.3645.02%
2016NZ$0.94-20.97%
2015NZ$1.19-14.97%
2014NZ$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$33.18 1,491.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$6.41 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$15.25 631.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$10.07 382.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.54 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.37-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$14.84 611.97%๐Ÿ‡บ๐Ÿ‡ธ USA